The potential role of Clostridium perfringens alpha toxin in the pathogenesis of acute pancreatitis

Journal of Clinical Pathology

Volumn 49, Issue 6, 1996, Pages 500-503

  Holdsworth, R J ^a   Parratt, D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Acute pancreatitis; Alpha toxin; Clostridium perfringens; Phospholipase C

Indexed keywords

ALPHA TOXIN; ANTITOXIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPASE C;

ACUTE PANCREATITIS; ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL; TISSUE NECROSIS;

EID: 0029989020     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.6.500     Document Type: Article

References (28)

1. Widdison AL, Karanjia ND. Pancreatic infection complicating acute pancreatitis. Br J Surg 1993;80:148-54.
2. Cuschieri A, Wood RAB, Meehan SE, Mackie CR. Treatment of acute pancreatitis with fresh frozen plasma. Br J Surg 1983;70:710-12.
3. Mann DV, Hershman MJ, Hittinger R, Glazer G. Multicentre audit of death from acute pancreatitis. Br J Surg 1994; 81:890-3.
4. Steer ML, Classification and pathogenesis of pancreatitis. Surg Clin North Am 1989;69:467-81.
5. Gorbach SL, Bartlett JG. Anaerobic infections. N Engl J Med 1974;290:1177-84, 1257-45, 1289-94.
6. Lorber B, Swenson RM. The bacteriology of intra-abdominal infections. Surg Clin North Am 1975;55:1349-61.
7. Keighley MRB, Drysdale RD, Quoraishi AH, Burdon AH, Alexander-Williams J. Antibiotic treatment of biliary sepsis. Surg Clin North Am 1975;55:1379-85.
8. Claesson BEB, Holmlund DEW, Matzsch TW. Microflora of the gall-bladder related to duration of acute cholecystitis. Surg Gynecol Obstet 1986;162:531-5.
9. SakaguchiY, Murata K, Kimura M. Clostridium perfringens and other anaerobes isolated from bile. J Clin Pathol 1983; 36:345-9.
10. Gustafson C, Tagesson C. Phospholipase C from Clostridium perfringens stimulates phospholipase A2-mediated arachidonic acid release in cultured intestinal epithelial cells. Scand J Gastroenterol 1990;25:363-7.
11. Holdsworth RJ, Parract D. Development of an ELISA assay for Clostridium perfringens phospholipase C (Alpha Toxin). J Immunoassay 1994;15:293-304.
12. Holdsworth RJ, McKenzie H, Parratt D, Irving AD, Cuschieri A. The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria. Int J Exp Pathol 1990,71:835-43.
13. Lund SJ. Detection of Clostridium perfringens phospholipase C and antibodies in serum and bile by enzyme-linked immunosorbent assay (ELISA) [BSc Honours Thesis]. Dundee: Univ of Dundee, 1995.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
15. Raahave D, Horn T. Gas gangrene of the omental bursa following acute pancreatitis. Scand J Infect Dis 1984; 16:207-9.
16. Morton AL, Taylor EW. Fatal clostridial pancreatitis following transduodenal biopsy of the pancreas. J R Coll Surg Edinb 1990;35:254.
17. Howard JM, Campbell EW. Fatal clostridial pancreatitis following ERCP and percutaneous needle biopsy. Int J Pancreatol 1989;5:305-10.
18. Feingold SM, Bartlett JG, Chow AW, Flora DJ, Gorbach SL, Harder ES, Tally FP. Management of anaerobic infections. Ann Intern Med 1975;83:375-89.
19. Mentzer RM, Golden GT, Chandler JG, Horsley JS. A comparative appraisal of emphysematous cholecystitis. Am J Surg 1975;129:10-15.
20. Ruby ST, Gladstone A, Treat M, Weber CJ. Emphysematous cholecystitis: a case report. JAMA 1983;249:248-9.
21. Pyrtek LJ, Bartus SH. Clostridium wechi infection complicating biliary tract surgery. N Engl J Med 1962;266:689-93.
22. Murrell JGC, Roth L, Egerton J, Samels J, Walker PD. Pigbel: enteritis necroticans. A study in diagnosis and treatment. Lancet 1966;i:217-22.
23. Lawrence G. Necrotizing enteritis and Clostridium perfringens. J Infect Dis 1986;153:803-5.
24. Van Kessel LJP, Verbrugh HA, Stringer MF, Hoekstra JBL. Necrotizing enteritis associated with toxigenic type A Clostridium perfringens. J Infect Dis 1985;151:974-5.
25. Titball RW, Leslie DL, Harvey S, Kelly D. Haemolytic and sphingomyelinase activities of Clostridium perfringens alpha toxin are dependent on a domain homologous to that of an enzyme from human arachidonic acid pathway. Infect Immun 1991;59:1872-4.
26. Chovnick A, SchneiderWP, Tso JY, Queen C, Chang CN. A recombinant, membrane-acting immunotoxin. Cancer Res 1991;51:465-7.
27. Styrt B, Walker RD, White JC. Neutophil oxidative metabolism after exposure to bacterial phospholipase C. J Lab Clin Med 1989;114:51-7.
28. Stevens DL, Troyer BE, Merrick DT, Mitten JE, Olsen RD. Lethal effects and cardiovascular effects of purified alpha and theta toxins from Clostridium perfringens. J Infect Dis 1988;157:272-9.